Sotera Health Co. (NASDAQ: SHC) reported Q4 EPS of $0.26, $0.02 better than the analyst estimate of $0.24. Revenue for the quarter came in at $303.44 million versus the consensus estimate of $299.51 million.

GUIDANCE:

Sotera Health Co. sees FY2026 EPS of $0.93-$1.01, versus the consensus of $0.94. Sotera Health Co. sees FY2026 revenue of $1.23-1.25 billion, versus the consensus of $1.23 billion.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.